ARCHIVES

DRG Executives Names By DeVita as Director Of DEA; Other Sections Reportedly Made, Not Yet Approved

This article is from The Cancer Letter archive.

Vol. 07 No. 31 | July 31, 1981

Download PDF Visit The Full Archive

Related Articles

Challoner: We Recommended FDA Replace 510(k) Clearance

July 4, 2014

New Subcommittee Chairman Named

June 10, 1977

FDA Proposes New User Fees for Generics and Biosimilar Products

January 20, 2012

Duke Plans To Restart Three Trials Using Tumor Microarray Analysis

January 29, 2010

Bush Budget Stresses Research Now, Public Health Interventions Later.

April 13, 2001

Bill To Teach Breast Self-Exam To Teens Wins Political Support; Experts Fear Harm

April 10, 2009